Centre Hospitalier Universitaire de Sherbrooke
Sherbrooke, Quebec, J1H5N4, Canada
NCT Number: NCT02975466
A "can't intubate, can't oxygenate" situation is life-threatening and the physician must be prepared to react quickly. Similarly, a difficult intubation with adequate ventilation is associated with complications. In both of these situation and as recommend by different societies, a supra-glottic airway (SGA) device can be used to help ventilation, or as an intubation conduit to ease the airway access. The objective of this randomized controlled trial is to establish which SGA, between the AuraGain, AirQ Blocker and I-Gel, allows the fastest intubation time in an adult population, with the objective of minimizing complications related to these situations. The investigators will conduct a three-arm trial to compare different outcomes related to the installation of the SGA and its use as an intubation conduit. The results of this trial will inform the anesthesiologist on which device to use on to have close in case of airway emergencies.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Sherbrooke, Quebec, J1H5N4, Canada
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Insertion of the SGA device and evaluation of easiness of endotracheal intubation
Insertion of the SGA device and evaluation of easiness of endotracheal intubation
Insertion of the SGA device and evaluation of easiness of endotracheal intubation
Time frame: Through study completion, an average of half an hour (no follow-up required)
This outcome corresponds to the time required to intubate with endotracheal tube (ET) through the supra-glottic airway device. The timer will be started when the flexible fiberoptic intubation scope is inserted in the SGA, and will be stopped when the air cuff of the ET is inflated inside the trachea and carbon dioxide (CO2) is obtained. This outcome will be assessed by the either the performer or second person responsible for data collection.
Time frame: Through study completion, an average of half an hour (no follow-up required)
This outcome is dichotomic and represents success of intubation through the SGA on the first attempt. An attempt will be defined as any lowering of the ET towards the glottis. Thus, any raise of the ET to its original position on the fiberoptic intubation scope will be considered as a failed attempt. Similarly, any removal of the fiberoptic scope from the SGA will be considered as a failed attempt, regardless of an attempt to lower the ET. This primary outcome is dichotomous and answers to the question: "Was the first attempt successful?"
Time frame: Through study completion, an average of half an hour (no follow-up required)
Regardless of the number of attempts, this outcome will be considered positive if the ET penetrated the trachea, the air cuff was inflated and capnography is positive, sustained and with normal values. A failed intubation would be, for example, to leave the SGA in place for the whole surgery or to remove the SGA to complete the endotracheal intubation.
Time frame: Through study completion, an average of half an hour (no follow-up required)
For example, the ET is lowered and does not enter the glottis, and is raised up again while the scope is removed from the SGA : "one" failed attempt will be noted. If the scope is entered in the SGA, no attempt to lower the ET and the scope is removed : "one" failed attempt will also be noted. However, if the scope is inserted in the SGA, the ET is lowered a first time and raised on the scope, and the ET is lowered a second time and raised again on the scope, "two" failed attempts will be considered.
Time frame: Through study completion, an average of half an hour (no follow-up required)
The time for whole procedure corresponds to the sum of the time required for installation of the SGA device and the time required for intubation through the device.
Time frame: Through study completion, an average of half an hour (no follow-up required)
An evaluation of the laryngeal view on the first attempt of fibroscopy will be evaluated by the attending anesthesiologist with the following scale :
Time frame: Through study completion, an average of half an hour (no follow-up required)
The easiness of insertion and ventilation will be graded using the following scale, as proposed by Talaat and al. in his trial on Air-Q and Fastrach devices.
Time frame: Through study completion, an average of half an hour (no follow-up required)
The easiness of intubation will be subjectively evaluated by the attending anesthesiologist using the following scale:
Time frame: Through study completion, an average of half an hour (no follow-up required)
The anesthesiologist will be asked to report a subjective evaluation of the removal of the SGA once the patient is intubated.
Time frame: Through study completion, an average of half an hour (no follow-up required)
The research team will report any adverse events. For example, accidental extubation during the removal of the SGA, blood on the device when removed, desaturation under 90%. As previously mentioned, if the attending anesthesiologist wants to stop the protocol for different reasons, as unsatisfactory ventilation, the standardized manipulations will be stopped and the anesthesiologist will pursue airway management according to his preferences.
Université de Sherbrooke
Other
Randomized Controlled Trial Comparing the Efficiency of Three Third Generation Supraglottic Airways as an Intubation Route
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06005701
Behavior, Bile Duct Diseases
Buraidah, Al-Qassim Region, Saudi Arabia
View Trial DetailsNCT06896513
Difficult Intubation, Difficult Laryngoscopy
Konya, Selçuklu, Turkey (Türkiye)
View Trial DetailsNCT07383610
Difficult Airway, Difficult Intubation
Kütahya, Turkey (Türkiye)
View Trial DetailsNCT07343557
Airway Assessment, Difficult Intubation
Adana, Turkey (Türkiye)
View Trial Details